67316 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

TABLE 1—RECIPIENTS AND AWARD AMOUNTS

Grant No. Award recipient name City, state Award amount 

U07MC37471 ................................ University of Texas at Austin ............................................................... Austin, TX .............. $1,000,000 

Justification: In fiscal year 2022, 

Congress provided additional funding 

for the PMHCA program and expanded 

the allowable activities for PMHCA 

programs to include support for hospital 

emergency departments to address the 

growing behavioral health needs among 

children and adolescents. This 

supplemental funding to the existing 

Emergency Medical Services for 

Children Innovation and Improvement 

Center recipient will support continued 

expansion of PMHCA programs in 

providing training and tele-consult 

support to providers in emergency 

departments and other settings, 

consistent with the additional authority 

enacted by Congress. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–21510 Filed 9–28–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Notice of Supplemental Award; 

National Center for Newborn Screening 

Systems Excellence Funding 

Supplement 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice of supplemental award. 

SUMMARY: HRSA will provide 

supplemental funding to the National 

Center for Newborn Screening Systems 

Excellence in fiscal year 2023. 

FOR FURTHER INFORMATION CONTACT: Kim 

Morrison, Public Health Analyst, 

Division of Services for Children with 

Special Health Needs, Maternal and 

Child Health Bureau, Health Resources 

and Services Administration, at 

KMorrison@hrsa.gov and 301–443–6672. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: The 

Association of Public Health 

Laboratories. 

Amount of Non-Competitive Award: 

$425,000. Supplemental funding for 

similar activities may be considered in 

fiscal year 2024, subject to availability 

of funding for the activity and 

satisfactory performance of the 

recipient. 

Project Period: July 1, 2023, to June 

30, 2028. 

CFDA Number: 93.110. 

Award Instrument: Supplement for 

Services. 

Authority: 42 U.S.C. 300b–8 (Public 

Health Service Act section 1109, as 

amended). 

TABLE 1—RECIPIENT AND AWARD AMOUNT

Grant No. Award recipient name City, state Award amount 

U22MC24078 ................................ Association of Public Health Laboratories ........................................... Silver Spring, MD ... $425,000 

Justification: The National Center for 

Newborn Screening Systems Excellence 

provides national leadership, technical 

assistance, and quality improvement 

expertise to state and territory newborn 

screening programs. Additional funding 

will support emerging needs in the 

newborn screening community and state 

laboratories, specifically addressing 

newborn screening condition naming, 

counting, testing, assessing health gaps 

in follow-up, and assessing domains of 

family outcomes. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–21512 Filed 9–28–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Vaccine Injury Compensation 

Program; List of Petitions Received 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HRSA is publishing this 

notice of petitions received under the 

National Vaccine Injury Compensation 

Program (the Program), as required by 

the Public Health Service (PHS) Act, as 

amended. While the Secretary of HHS is 

named as the respondent in all 

proceedings brought by the filing of 

petitions for compensation under the 

Program, the United States Court of 

Federal Claims is charged by statute 

with responsibility for considering and 

acting upon the petitions. 

FOR FURTHER INFORMATION CONTACT: For 

information about requirements for 

filing petitions, and the Program in 

general, contact Lisa L. Reyes, Clerk of 

Court, United States Court of Federal 

Claims, 717 Madison Place NW, 

Washington, DC 20005, (202) 357–6400. 

For information on HRSA’s role in the 

Program, contact the Director, National 

Vaccine Injury Compensation Program, 

5600 Fishers Lane, Room 08N146B, 

Rockville, Maryland 20857; (301) 443– 

6593, or visit our website at: http://

www.hrsa.gov/vaccinecompensation/ 

index.html. 

SUPPLEMENTARY INFORMATION: The 

Program provides a system of no-fault 

compensation for certain individuals 

who have been injured by specified 

childhood vaccines. Subtitle 2 of title 

XXI of the PHS Act, 42 U.S.C. 300aa– 

10 et seq., provides that those seeking 

compensation are to file a petition with 

the United States Court of Federal 

Claims and to serve a copy of the 

petition to the Secretary of HHS, who is 

named as the respondent in each 

proceeding. The Secretary has delegated 

this responsibility under the Program to 

HRSA. The Court is directed by statute 

to appoint special masters who take 

evidence, conduct hearings as 

appropriate, and make initial decisions 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 67317 

as to eligibility for, and amount of, 

compensation. 

A petition may be filed with respect 

to injuries, disabilities, illnesses, 

conditions, and deaths resulting from 

vaccines described in the Vaccine Injury 

Table (the Table) set forth at 42 CFR 

100.3. This Table lists for each covered 

childhood vaccine the conditions that 

may lead to compensation and, for each 

condition, the time period for 

occurrence of the first symptom or 

manifestation of onset or of significant 

aggravation after vaccine 

administration. Compensation may also 

be awarded for conditions not listed in 

the Table and for conditions that are 

manifested outside the time periods 

specified in the Table, but only if the 

petitioner shows that the condition was 

caused by one of the listed vaccines. 

Section 2112(b)(2) of the PHS Act, 42 

U.S.C. 300aa–12(b)(2), requires that 

‘‘[w]ithin 30 days after the Secretary 

receives service of any petition filed 

under section 2111 the Secretary shall 

publish notice of such petition in the 

Federal Register.’’ Set forth below is a 

list of petitions received by HRSA on 

August 1, 2023, through August 31, 

2023. This list provides the name of the 

petitioner, city, and state of vaccination 

(if unknown then the city and state of 

the person or attorney filing the claim), 

and case number. In cases where the 

Court has redacted the name of a 

petitioner and/or the case number, the 

list reflects such redaction. 

Section 2112(b)(2) also provides that 

the special master ‘‘shall afford all 

interested persons an opportunity to 

submit relevant, written information’’ 

relating to the following: 

1. The existence of evidence ‘‘that 

there is not a preponderance of the 

evidence that the illness, disability, 

injury, condition, or death described in 

the petition is due to factors unrelated 

to the administration of the vaccine 

described in the petition,’’ and 

2. Any allegation in a petition that the 

petitioner either: 

a. ‘‘[S]ustained, or had significantly 

aggravated, any illness, disability, 

injury, or condition not set forth in the 

Vaccine Injury Table but which was 

caused by’’ one of the vaccines referred 

to in the Table, or 

b. ‘‘[S]ustained, or had significantly 

aggravated, any illness, disability, 

injury, or condition set forth in the 

Vaccine Injury Table the first symptom 

or manifestation of the onset or 

significant aggravation of which did not 

occur within the time period set forth in 

the Table but which was caused by a 

vaccine’’ referred to in the Table. 

In accordance with section 2112(b)(2), 

all interested persons may submit 

written information relevant to the 

issues described above in the case of the 

petitions listed below. Any person 

choosing to do so should file an original 

and three (3) copies of the information 

with the Clerk of the United States 

Court of Federal Claims at the address 

listed above (under the heading ‘‘For 

Further Information Contact’’), with a 

copy to HRSA addressed to Director, 

Division of Injury Compensation 

Programs, Health Systems Bureau, 5600 

Fishers Lane, 08N146B, Rockville, 

Maryland 20857. The Court’s caption 

(Petitioner’s Name v. Secretary of HHS) 

and the docket number assigned to the 

petition should be used as the caption 

for the written submission. Chapter 35 

of Title 44, United States Code, related 

to paperwork reduction, does not apply 

to information required for purposes of 

carrying out the Program. 

Carole Johnson, 

Administrator. 

List of Petitions Filed 

1. Caitlyn Kuykendall, Ennis, Texas, Court of 

Federal Claims No: 23–1198V 

2. Robert Haas, San Pedro, California, Court 

of Federal Claims No: 23–1199V 

3. Kayla Goggans, Greenbelt, Maryland, Court 

of Federal Claims No: 23–1200V 

4. Michele O’Connell, Olivebridge, New 

York, Court of Federal Claims No: 23– 

1205V 

5. Kirsten Bowland, Nottingham, Maryland, 

Court of Federal Claims No: 23–1206V 

6. Scott Stevens on behalf of Evan Stevens, 

Minneapolis, Minnesota, Court of 

Federal Claims No: 23–1207V 

7. Skylar Allen, Beverly, New Jersey, Court 

of Federal Claims No: 23–1209V 

8. Ava Chang, Sacramento, California, Court 

of Federal Claims No: 23–1213V 

9. Jocelyn Vazquez, Park Ridge, Illinois, 

Court of Federal Claims No: 23–1217V 

10. Jozsef Pocsi, Orlando, Florida, Court of 

Federal Claims No: 23–1220V 

11. Vaughn Costello, Washington, District of 

Columbia, Court of Federal Claims No: 

23–1228V 

12. Sonia Narvaez, Cape Coral, Florida, Court 

of Federal Claims No: 23–1231V 

13. Kevin Brown, Sarasota, Florida, Court of 

Federal Claims No: 23–1235V 

14. Camille Wainer, Fort Worth, Texas, Court 

of Federal Claims No: 23–1245V 

15. Meghan Gamboa, Las Vegas, Nevada, 

Court of Federal Claims No: 23–1253V 

16. Deana Cookson, Watertown, Wisconsin, 

Court of Federal Claims No: 23–1254V 

17. Sascha Hirrle on behalf of L. H., Chicago, 

Illinois, Court of Federal Claims No: 23– 

1256V 

18. Teresa Mimms, Lafayette, Indiana, Court 

of Federal Claims No: 23–1258V 

19. Zaher Fayyad, Sterling Heights, 

Michigan, Court of Federal Claims No: 

23–1260V 

20. Eric Traiger, West Orange, New Jersey, 

Court of Federal Claims No: 23–1267V 

21. Marlene Swords, York, Pennsylvania, 

Court of Federal Claims No: 23–1270V 

22. Karina Frecka, Racine, Wisconsin, Court 

of Federal Claims No: 23–1271V 

23. Carolyn Worlds, Fort Wayne, Indiana, 

Court of Federal Claims No: 23–1272V 

24. Greg Spayd, State College, Pennsylvania, 

Court of Federal Claims No: 23–1273V 

25. Joyce Allred, Springfield, Missouri, Court 

of Federal Claims No: 23–1274V 

26. Jaimee Palm on behalf of H. D., Phoenix, 

Arizona, Court of Federal Claims No: 23– 

1280V 

27. Andrew Luksch, Depew, New York, Court 

of Federal Claims No: 23–1281V 

28. Harris Paltrowitz, New York City, New 

York, Court of Federal Claims No: 23– 

1283V 

29. Michael Doby, Livonia, Michigan, Court 

of Federal Claims No: 23–1285V 

30. Marc Sanders, Phoenix, Arizona, Court of 

Federal Claims No: 23–1287V 

31. Richard Lewis Foss, Birmingham, 

Alabama, Court of Federal Claims No: 

23–1288V 

32. Gloria Hernandez, Jersey City, New 

Jersey, Court of Federal Claims No: 23– 

1290V 

33. Raul Barrios, Bronx, New York, Court of 

Federal Claims No: 23–1291V 

34. Laura Weissbach, Tigard, Oregon, Court 

of Federal Claims No: 23–1293V 

35. Diane Newcomb, Natick, Massachusetts, 

Court of Federal Claims No: 23–1294V 

36. Saul Antonio Torres-Barrera, San Pedro, 

California, Court of Federal Claims No: 

23–1295V 

37. Elizabeth Young, Charlotte, North 

Carolina, Court of Federal Claims No: 

23–1297V 

38. Laquila Brown, Phoenix, Arizona, Court 

of Federal Claims No: 23–1299V 

39. Chaim Greenfeld on behalf of C. G., New 

York, New York, Court of Federal Claims 

No: 23–1301V 

40. Angela Armstrong, Lebanon, Missouri, 

Court of Federal Claims No: 23–1304V 

41. Karen Bowie, Dallas, Texas, Court of 

Federal Claims No: 23–1306V 

42. Kevin W. Craig, State College, 

Pennsylvania, Court of Federal Claims 

No: 23–1311V 

43. Glenn E. Clapsaddle, Jefferson, Ohio, 

Court of Federal Claims No: 23–1312V 

44. Maria V. Paltrinieri Baclini, Miami, 

Florida, Court of Federal Claims No: 23– 

1313V 

45. Michael Stage, Florissant, Missouri, Court 

of Federal Claims No: 23–1314V 

46. Stephanie Bennett, Boston, 

Massachusetts, Court of Federal Claims 

No: 23–1315V 

47. Pablo Mendoza, Horizon City, Texas, 

Court of Federal Claims No: 23–1318V 

48. Carolyn M. Fenwick, Southwick, 

Massachusetts, Court of Federal Claims 

No: 23–1320V 

49. Sierra White on behalf of K. W., New 

York, New York, Court of Federal Claims 

No: 23–1321V 

50. Nancy Ajolo, Honolulu, Hawaii, Court of 

Federal Claims No: 23–1323V 

51. Steve Mobley, Fort Worth, Texas, Court 

of Federal Claims No: 23–1324V 

52. Shelly Wigler on behalf of A. W., Newton, 

Pennsylvania, Court of Federal Claims 

No: 23–1325V 

53. Jermaine A. Beale, Memphis, Tennessee, 


lotter on DSK11XQN23PROD with NOTICES1
67318 Federal Register / Vol. 88, No. 188 / Friday, September 29, 2023 / Notices 

Court of Federal Claims No: 23–1326V 

54. Silvia Aguayo, Lancaster, California, 

Court of Federal Claims No: 23–1327V 

55. Katie B. Tate, Los Angeles, California, 

Court of Federal Claims No: 23–1342V 

56. Savana Torres, Los Angeles, California, 

Court of Federal Claims No: 23–1343V 

57. Linda Orbanac, Sayre, Pennsylvania, 

Court of Federal Claims No: 23–1344V 

58. Angela Battles, White, Georgia, Court of 

Federal Claims No: 23–1345V 

59. Mark E. Hanson, Minneapolis, Minnesota, 

Court of Federal Claims No: 23–1346V 

60. Beata Brozek, Evanston, Illinois, Court of 

Federal Claims No: 23–1347V 

61. Melissa Thomas on behalf of M. T., 

Wilmington, North Carolina, Court of 

Federal Claims No: 23–1351V 

62. Danyel Nelson, Warwick, Rhode Island, 

Court of Federal Claims No: 23–1352V 

63. John Schouest, Thibodaux, Louisiana, 

Court of Federal Claims No: 23–1353V 

64. Nicole Sicuro-Leipski on behalf of G. L., 

Kenosha, Wisconsin, Court of Federal 

Claims No: 23–1356V 

65. Shalonda Goolsby, Dresher, 

Pennsylvania, Court of Federal Claims 

No: 23–1357V 

66. Alice McCarthy, Renton, Washington, 

Court of Federal Claims No: 23–1360V 

67. Yesid Hernandez, Naples, Florida, Court 

of Federal Claims No: 23–1364V 

68. Leah Keller, Washington, District of 

Columbia, Court of Federal Claims No: 

23–1367V 

69. Bethel Stevens, Waimea, Hawaii, Court of 

Federal Claims No: 23–1369V 

70. Dolores Jefferson, Fairburn, Georgia, 

Court of Federal Claims No: 23–1370V 

71. Dawn Ferris-Murray, Mount Laurel, New 

Jersey, Court of Federal Claims No: 23– 

1380V 

72. Jeremy Allred, Minneapolis, Minnesota, 

Court of Federal Claims No: 23–1385V 

73. Mary Louise Spann, Nashville, 

Tennessee, Court of Federal Claims No: 

23–1395V 

74. Vincent Russell, West Chester, 

Pennsylvania, Court of Federal Claims 

No: 23–1397V 

75. Larry Cunningham, Aurora, Colorado, 

Court of Federal Claims No: 23–1404V 

76. Chinyere Jumbo, Hoover, Alabama, Court 

of Federal Claims No: 23–1419V 

77. Chinyere Jumbo, Hoover, Alabama, Court 

of Federal Claims No: 23–1421V 

78. Leora Chasen, Binghamton, New York, 

Court of Federal Claims No: 23–1423V 

79. Steven Hofmaster, Camas, Washington, 

Court of Federal Claims No: 23–1430V 

80. Aislynn Hayes, Murfreesboro, Tennessee, 

Court of Federal Claims No: 23–1448V 

81. Bobby Rossette, Boston, Massachusetts, 

Court of Federal Claims No: 23–1477V 

82. Maria Bettinger, Houston, Texas, Court of 

Federal Claims No: 23–1478V 

83. Candy Guzman-Guizar, Alhambra, 

California, Court of Federal Claims No: 

23–1484V 

84. Brian Andrew Vergara, Phoenix, Arizona, 

Court of Federal Claims No: 23–1486V 

85. Yoshua Rozen, Boston, Massachusetts, 

Court of Federal Claims No: 23–1487V 

86. Kristen Edwards Dempsey, Honolulu, 

Hawaii, Court of Federal Claims No: 23– 

1493V 

87. Andrea Mae Warren, Honolulu, Hawaii, 

Court of Federal Claims No: 23–1494V 

88. Gina Lewis, Sterling, Kansas, Court of 

Federal Claims No: 23–1495V 

89. Ollie Phillips, Woodridge, Illinois, Court 

of Federal Claims No: 23–1496V 

90. Elizabeth Herman, West Chester, 

Pennsylvania, Court of Federal Claims 

No: 23–1497V 

91. John Bovard, Boston, Massachusetts, 

Court of Federal Claims No: 23–1498V 

92. Kandi Shafer, Woodridge, Illinois, Court 

of Federal Claims No: 23–1499V 

93. John Yankey, Canby, Oregon, Court of 

Federal Claims No: 23–1500V 

94. Tynh Maejlauk, Chandler, Arizona, Court 

of Federal Claims No: 23–1501V 

95. Linda Shaw, DeLand, Florida, Court of 

Federal Claims No: 23–1502V 

96. Lashay Cameron on behalf of N. C., Jr., 

Deceased, Aventura, Florida, Court of 

Federal Claims No: 23–1505V 

97. Rebecca Furdell, Cape Coral, Florida, 

Court of Federal Claims No: 23–1506V 

98. Margaret Covino, Worcester, 

Massachusetts, Court of Federal Claims 

No: 23–1508V 

99. Bartolomeo Marano, Boston, 

Massachusetts, Court of Federal Claims 

No: 23–1509V 

100. Lynda Speer, Washington, District of 

Columbia, Court of Federal Claims No: 

23–1511V 

[FR Doc. 2023–21498 Filed 9–28–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Notice of Request for Public 

Comments on a Draft 

Recommendation To Update the 

HRSA-Supported Women’s Preventive 

Services Guideline Relating to 

Screening for Urinary Incontinence 

AGENCY: Health Resources and Services 

Administration (HRSA), U. S. 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: This notice seeks comments 

on a draft recommendation to update 

the HRSA-supported Women’s 

Preventive Services Guidelines 

(‘‘Guidelines’’) relating to Screening for 

Urinary Incontinence. This draft 

recommendation has been developed 

through a cooperative agreement, 

known as the Women’s Preventive 

Services Initiative (WPSI), with the 

American College of Obstetricians and 

Gynecologists (ACOG), through which 

they convene health professionals to 

develop draft recommendations. Under 

applicable law, non-grandfathered 

group health plans and health insurance 

issuers must include coverage, without 

cost sharing, for certain preventive 

services, including those provided for in 

the HRSA-supported Guidelines. The 

Departments of Labor, Health and 

Human Services, and Treasury have 

previously issued regulations, which 

describe how group health plans and 

health insurance issuers apply the 

coverage requirements. 

DATES: Members of the public are 

invited to provide written comments no 

later than October 30, 2023. All 

comments received on or before this 

date will be reviewed and considered by 

WPSI and provided for further 

consideration by HRSA in determining 

the recommended update that it will 

support. 

ADDRESSES: Members of the public who 

wish to provide comments can do so by 

accessing the public comment web page 

at https://www.womenspreventive

health.org/. 

FOR FURTHER INFORMATION CONTACT: 

Kimberly Sherman, HRSA, Maternal 

and Child Health Bureau, telephone 

(301) 443–8283, email: wellwomancare@

hrsa.gov. 

SUPPLEMENTARY INFORMATION: Under 

section 1001(5) of the Patient Protection 

and Affordable Care Act, Public Law 

111–148, which added section 2713 to 

the Public Health Service Act, 42 U.S.C. 

300gg-13, the preventive care and 

screenings set forth in the Guidelines 

are required to be covered without costsharing by certain group health plans 

and health insurance issuers. HRSA 

established the Guidelines in 2011 

based on expert recommendations by 

the Institute of Medicine, now known as 

the National Academy of Medicine, 

developed under a contract with the 

Department of Health and Human 

Services. Since 2011, there have been 

advancements in science and gaps 

identified in these guidelines, including 

a greater emphasis on practice-based 

clinical considerations. Since 2016, 

HRSA has funded cooperative 

agreements with ACOG for WPSI to 

convene a coalition representing 

clinicians, academics, and consumerfocused health professional 

organizations to conduct a rigorous 

review of current scientific evidence, 

solicit and consider public input, and 

make recommendations to HRSA 

regarding updates to the Guidelines to 

improve women’s health across the 

lifespan. HRSA then determines 

whether to support, in whole or in part, 

the recommended updates to the 

Guidelines. WPSI consists of an 

Advisory Panel and two expert 

committees, the Multidisciplinary 

Steering Committee and the 

Dissemination and Implementation 


lotter on DSK11XQN23PROD with NOTICES1